Sabrina Arena

20PUBLICATIONS
114CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 19, 2026
WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

|Aug 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.

Lisa Brunet, David Alexandre, Jiyoung Lee

|May 23, 2025
TRPM8 levels determine tumor vulnerability to channel agonists.

Alessandro Alaimo, Francesco Giuseppe Carbone, Kristi Buzo

|Apr 28, 2025
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.

Michelangelo Marasco, Dinesh Kumar, Santiago Garcia Borrego

|Oct 14, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition.

Giorgio Corti, Kristi Buzo, Enrico Berrino

|May 15, 2024
Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients.

Giada De Lazzari, Alena Opattova, Sabrina Arena

Pageof 4

Frequent Collaborators

9 joint publications

Federica Di Nicolantonio

9 joint publications

Salvatore Siena

6 joint publications

Alberto Bardelli

6 joint publications

Andrea Sartore-Bianchi